Caption Management, LLC Eli Lilly & CO Put Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $10.5 Million - $12.4 Million	20,000 New	20,000 $11.7 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $10.9 Million - $12.4 Million	36,700 New	36,700 $11.9 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $2.67 Million - $3.07 Million	-35,300 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $2.62 Million - $3.09 Million	35,300 New	35,300 $2.73 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.